Developmental Disabilities: Clinical Trials

3 trials for Developmental Disabilities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Developmental Disabilities: new trials by email Literature Review of Developmental Disabilities trials Research Report on Developmental Disabilities

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
Swallow instruction - Epilepsy, Mental Retardation
Phase 4CompletedChildren's National Research Institute202005-08-012008-05-05
Vanderbilt University Spasticity Management Program Evaluation Plan
Botulinum Toxin Type A, Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB) - Spasticity
Phase 4CompletedVanderbilt University202002-08-012007-08-20
Methylphenidate Study in Young Children With Developmental Disorders
Methylphenidate - Attention Deficit Hyperactivity Disorder
Phase 4CompletedUniversity of Arizona482001-05-012012-07-04

Narrower conditions

Attention Deficit Disorder with Hyperactivity (1)  ·  Epilepsy (1)  ·  Intellectual Disability (1)  ·  Learning Disabilities (1)  ·  Muscle Spasticity (1)  ·  Seizures (1)

Broader conditions

Mental Disorders (3)  ·  Neurodevelopmental Disorders (3)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Muscle Hypertonia (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neuromuscular Manifestations (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Methylphenidate (1)

Sponsors

Children's National Research Institute (1)  ·  University of Arizona (1)  ·  Vanderbilt University (1)

Countries

United States (2)

Top investigators

David Charles, MD (1)  ·  Jaswinder K Ghuman, M.D. (1)  ·  Joan A Conry, MD (1)